Put Options

16 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $566,865 - $657,747
-5,100 Reduced 34.0%
9,900 $1.12 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $619,000 - $664,800
5,000 Added 50.0%
15,000 $1.86 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $634,144 - $738,919
5,600 Added 127.27%
10,000 $1.32 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $260,468 - $283,452
-2,600 Reduced 37.14%
4,400 $479,000
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $308,850 - $342,990
-3,000 Reduced 30.0%
7,000 $720,000
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $1.09 Million - $1.18 Million
-10,000 Reduced 50.0%
10,000 $1.15 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $2.05 Million - $2.29 Million
19,900 Added 19900.0%
20,000 $2.13 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $874,400 - $1.12 Million
-10,000 Reduced 99.01%
100 $11,000
Q2 2022

Aug 17, 2022

SELL
$83.49 - $94.64 $75,141 - $85,176
-900 Reduced 8.18%
10,100 $921,000
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $257,285 - $288,400
3,500 Added 46.67%
11,000 $903,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $122,876 - $153,918
1,700 Added 29.31%
7,500 $575,000
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $1.12 Million - $1.55 Million
-17,700 Reduced 75.32%
5,800 $446,000
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $2.56 Million - $2.92 Million
-36,800 Reduced 61.03%
23,500 $1.95 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $1.84 Million - $2.14 Million
28,200 Added 87.85%
60,300 $4.61 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $126,918 - $149,248
2,200 Added 7.36%
32,100 $2.28 Million
Q2 2018

Aug 03, 2018

BUY
$50.83 - $59.72 $1.52 Million - $1.79 Million
29,900 New
29,900 $1.82 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.